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Chimeric molecules consisting of parts from the sarcoplasmic reticulum Ca”-ATPase and the Na+,K’-ATPase were expressed in COS-1 cells and 
analysed functionally. One chimera, in which most of the central cytoplasmic loop was derived from the Na’,K+-ATPase, while the transmembrane 
segments and the minor cytoplasmic loop came from the Ca*‘-ATPase, was able to occlude Ca” and to be phosphorylated from ATP with normal 
apparent affinity for Ca*+ and ATP. This chimera also displayed normal sensitivity to thapsigargin, but was unable to undergo the transition from 
ADP-sensitive to ADP-insensitive phosphoenzyme and to transport Ca 2+ The other chimera, which consisted of the NH,-terminal two-thirds of . 
Na’,K’-ATPase and the COOH-terminal one-third of Ca*‘-ATPase, was unable to phosphorylate from ATP, but phosphotylated from inorganic 
phosphate in a Ca’+-inhibitable and thapsigargin-insensitive reaction. These results can be explained in terms of a structural model in which the 
non-conserved residues in the central cytoplasmic domain of the Ca2’-ATPase are without major importance for the binding and occlusion of Ca”, 
but are involved in the ElP-+EZP conformational changes of the phosphoenzyme, whereas residues in transmembrane segments on both sides of 
the central cytoplasmic domain are involved in formation of the Ca”-binding sites. The data moreover show that thapsigargin sensitivity is 
dependent on residues in the NH,-terminal one-third of the Ca”-ATPase molecule. 
Ca” occlusion; Ca2’-pump; Chimera; Na’,K’-pump; Thapsigargin 
1. INTRODUCTION 
The Ca”-ATPase of sarcoplasmic reticulum (SR) 
and the Na’,K+-ATPase of mammalian plasma mem- 
branes both belong to the P-type family of membrane 
bound cation transporting ATPases. Detailed amino 
acid sequence comparisons have shown that it is possi- 
ble to align the sequences of P-type ATPases with differ- 
ent cation selectivity [l], and although the existence of 
a consensus tructure for P-type ATPases has only in 
part been confirmed by more direct methods, it seems 
clear that the basic structural elements of these ATPases 
are similar, consisting of two cytoplasmic domains an- 
chored to a membrane sector that most likely is made 
up from an even number (8 or 10) of transmembrane 
a-helices. A central issue in the elucidation of structure- 
function relationships in the P-type ATPases is the loca- 
tion of the binding sites for the transported cations and 
ATP [24]. The understanding of the transport mecha- 
nism would in addition be furthered by identification of 
residues involved in the binding of specific inhibitors 
that prevent cation binding or conformational changes. 
One such inhibitor is thapsigargin, which acts specifi- 
cally on the sarco(endo)plasmic reticulum Ca”- 
ATPases to reduce the Ca*’ affinity [5,6]. 
*Corresponding authors. Fax: (45) (86) 12 90 65. 
Abbreviations: Ca*‘-ATPase Ca*‘-activated adenosine triphos- 
phatase; C,,E,, octaethyleneglycol monododecyl ether; ElP, ADP- 
sensitive phosphoenzyme intermediate; E2P, ADP-insensitive phos- 
phoenzyme intermediate; EGTA, [ethylenebis(oxyethylene-nitrilo)] 
tetraacetic acid; Ml-MlO, putative transmembrane segments num- 
bered from the NH,-terminal end of the peptide; MES, 2-(N-mor- 
pholino)ethanesulfonic acid; MOPS, 3-(N-morpholino)propane- sul- 
fonic acid; Na+,K+-ATPase, Na+- and K’-activated adenosine tri- 
phosphatase; TES, N-tris[hydroxymethyl]methyl-2-aminoethanesul- 
fonic acid; SDS, sodium dodecyl sulfate; SR, sarcoplasmic reticulum. 
The use of site-directed mutagenesis has provided a 
wealth of information regarding the functional roles of 
single amino acid residues in the sarcoplasmic reticulum 
Ca*‘-ATPase. Hence, these studies have identified resi- 
dues of importance for Ca*+ binding [7,8], ATP binding 
and phosphorylation [3,9], and ElP+E2P [lo-121 as 
well as E2P+E2 [ 12-141 conformational changes. All 
residues found to be crucial to ATP binding and phos- 
phorylation are located in the central cytoplasmic do- 
main, whereas residues that appear to be involved in 
Ca*’ binding are located in the putative transmembrane 
segments [3]. This points to a physical separation of 
‘phosphorylation’ and ‘Ca*‘-binding’ domains, which 
seems to be supported also by the use of proteolytic 
degradation methods [4]. Somewhat surprisingly, most 
of the residues with a potential role as Ca*+ ligands are 
highly conserved among the P-type ATPases [1,2,7]. 
Thus, the variable residues that directly or indirectly 
determine the cation selectivity of the ATPases remain 
to be identified. Information is also lacking concerning 
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the roles of the large number of non-conserved residues 
present in the central cytoplasmic domain. 
To address these problems it should be useful to study 
chimeric constructs, in which whole peptide segments 
have been swopped between ATPases of different cation 
selectivity. The basic similarity between the overall 
structures of P-type ATPases deduced from the amino 
acid sequences eems to provide a sound theoretical 
basis for the construction of such chimeric ATPases. In 
principle, studies of chimeric molecules should make it 
feasible to evaluate the functional significance of several 
substitutions of non-conserved residues and also to test 
the current ideas regarding domain structure and 
boundaries. If the assumption of a common structure 
of the various P-type ATPases holds, and the ATP and 
cation binding domains are separate, it might be feasible 
to exchange the ATP binding domains without change 
of cation selectivity. 
Recently, functional chimeric P-type ATPases have 
been produced, although the information on their enzy- 
matic properties was limited by low expression levels 
[15,16]. In the present study, we have constructed two 
chimeric molecules consisting of parts of Ca”-ATPase 
and Na’,K’-ATPase (Fig. l), and we have taken advan- 
tage of the relatively high expression efficiency obtained 
with the COS-1 cell system to carry out a detailed func- 
tional analysis of these chimeric ATPases, using phos- 
phorylation and occlusion assays developed previously 
for analysis of point mutants [8,10,11]. 
2. MATERIALS AND METHODS 
To construct chimeric cDNAs by exchange of cDNA fragments 
between the rabbit fast twitch muscle Ca”-ATPase (SERCAla) 
cDNA [9] and the rat kidney al Na+,K’-ATPase cDNA [17], oligonu- 
cleotide-directed mutagenesis [18] was used. to introduce unique re- 
striction sites in highly conserved areas (Fig. 1) without changing the 
amino acid sequences encoded by the cDNAs. One site (N&I) was 
introduced in the cDNA sequence ncoding amino acid residues 348- 
349, the other (@I) was introduced in the cDNA sequence ncoding 
amino acid residues 705-706 (numbering referring to the SR Ca2’- 
ATPase). The presence of the correct mutation was confirmed by 
nucleotide sequencing by the dideoxynucleotide chain termination 
method with modiications as described [1 11. 
The full-length Ca*+-ATPase/Na+,K’-ATPase chimeric cDNAs 
were cloned into the expression vector pMT2 [19], and the cesium 
chloride gradient-purified plasmids were transfected into COS-1 cells 
by the calcium phosphate procedure [17]. Microsomes were prepared 
from the cells 48860 h after the transfection as described in [9]. In some 
experiments we used an alternative preparation procedure described 
in [ 17] to obtain a high yield of plasma membrane derived microsomes. 
Immunoblotting following SDS-polyacrylamide gel electrophoresis 
was carried out as in [11] using monospecific anti-Ca”-ATPase anti- 
bodies raised against synthetic peptides [20]. Ca*+-activated ATP- 
driven Ca*’ transport was assayed by Millipore filtration [1 I]. Phos- 
phorylation from [Y-~~P]ATP or 32P, and the ADP-sensitivity of the 
phosphoenzymes was measured as previously [ 10, 11,131 with modifi- 
cations as described in the figure legends. To study thapsigargin- 
inhibition of phosphorylation, the microsomes were preincubated for 
30 min with the indicated concentration of thapsigargin. All phospho- 
rylation experiments were performed at least two times with closely 
agreeing results. After acid precipitation, the phosphorylated micro- 
somal protein was washed and subjected to SDS-polyacrylamide gel 
electrophoresis at pH 6.0 followed by autoradiography of the dried 
gels and quantitation by densitometric analysis using an LKB 2202 
Ultroscan Laser Densitometer. 
Ca*’ occlusion was measured essentially as described in [S]. In brief, 
the isolated microsomal membranes were incubated for 4 h at 20°C 
in 300,fd of a reaction mixture containing 10pM 45Ca2+, 1 mM CrATP, 
5 mM MgZf, 0.1 M NaCl, and 50 mM TES/Tris buffer (pH 7.0). 
Following this incubation, the membranes were solubilized by addi- 
tion of the non-ionic detergent &Es at a concentration of 5 mglml. 
Insoluble material was removed by centrifugation for 30 min in a 
Beckman Airfuge at 130,000 x g, and 250 ~1 of the supematant was 
subjected to molecular sieve HPLC in a TSK G 4000 SW column 
(TosoHaas) in the presence of 1.5 mM non-radioactive Car’ in the 
eluant. The collected fractions were analysed for radioactivity by liq- 
uid scintillation counting and for Ca”-ATPase content by im- 
munoblotting as described above. 
3. RESULTS 
The cDNAs encoding the chimeric fusion proteins 
shown in Fig. 1 were expressed transiently in transfected 
COS-1 cells. In Chimera A, most of the largest cytoplas- 
mic loop is derived from the Na’,K+-ATPase, while the 
transmembrane segments and the minor cytoplasmic 
loop comes from the Ca*‘-ATPase. Chimera B consists 
of the NH,-terminal two thirds of Na’,K+-ATPase and 
the COOH-terminal one third of Ca”-ATPase. Thus, in 
both cases the expression could be analysed using mon- 
ospecific antibodies against characteristic Ca*‘-ATPase 
sequences in the COOH-terminal one third of the mole- 
cule. Since the Na’,K+-ATPase is transported to the 
plasma membrane and the SR Ca*‘-ATPase to the en- 
doplasmic reticulum, we used two different methods for 
preparation of membrane fractions. One method [9] led 
to microsomes with a reduced plasma membrane con- 
tent, whereas the other method [17] resulted in a prepa- 
ration enriched with plasma membrane. For as well 
Chimera A as Chimera B, the former preparation pro- 
cedure gave the highest yield as judged from im- 
munoreactivity, indicating that the chimeric proteins 
were retained predominantly in the endoplasmic reticu- 
lum, and this preparation procedure was subsequently 
used. 
A B 
- Ca-ATPase 
- Na,K-ATPase 
Fig. 1. Schematic representation of the chimeric fusion proteins exam- 
ined in the present study. The ‘P’ indicates the phosphorylated aspartic 
acid residue. Numbers locate points of recombination (referring to the 
Ca”-ATPase). 
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Fig. 2. Examination of expression by immunoblotting. Microsomes 
from COS-1 cells transfected with either wild-type Ca*‘-ATPase 
cDNA (lane l), cDNA encoding Chimera A (lane 2) or Chimera B 
(lane 3), or microsomes from cells that had been mock-transfected 
with the vector without insert (lane 4), were subjected to SDS-poly- 
acrylamide gel electrophoresis followed by transfer to nitrocellulose. 
Equal amounts of total microsomal protein were loaded in the lanes. 
The blot was developed using antibody raised against the sequence 
GFNPPDLDIMD (residues 808-818 in SR Ca’+-ATPase) in combi- 
nation with alkaline phosphatase-conjugated goat anti-rabbit second- 
ary antibody. The arrows indicate molecular weight standards. 
Fig. 2 shows an example of an immunoblot of ex- 
pressed wild-type Ca*‘-ATPase and the chimeric 
ATPases, which had been subjected to SDS-poly- 
acrylamide gel electrophoresis. In this experiment, an 
antibody raised against a peptide corresponding to res- 
idues 808-818 of the SR Ca*‘-ATPase [20] was used to 
visualize the protein. In addition to the expressed wild- 
type Ca*‘-ATPase and the chimeric ATPases, which 
migrated corresponding to molecular weights between 
116,000 and 84,000, an endogenous COS-cell protein 
with apparent molecular weight close to 140,000 is seen 
to react with the antibody. The chimeric proteins did 
not migrate corresponding to exactly the same relative 
molecular mass as the wild-type Ca*‘-ATPase. Presum- 
ably, this was due to the difference in the number and 
charge of the residues (wild-type Ca*‘-ATPase: 994 res- 
idues, 27 net negative charges; Chimera A: 983 residues, 
36 net negative charges; Chimera B: 1003 residues, 36 
net negative charges). 
Quantitation of expression levels by comparison with 
known amounts of Ca*‘-ATPase on immunoblots simi- 
lar to that shown in Fig. 2 indicated that the yield of 
Chimera A varied between 70% and 150% that of the 
wild type, while the yield of Chimera B varied between 
10% and 45% that of the wild type, in 5 transfections. 
The Ca*’ transport activities of the chimeric mole- 
cules and the wild-type Ca*‘-ATPase were examined at 
Ca*’ concentrations up to 50 ,uM using a filtration assay 
following 10 min incubation of the microsomes with 
45Ca2+ and 5 mM MgATP at 27 “C [l 11. In Chimera A 
as well as Chimera B, the Ca*’ transport rate was im- 
measurably low, i.e. < 5% that of the wild-type Ca*‘- 
ATPase. In Chimera A, Ca*+ binding at high affinity 
sites could nevertheless be demonstrated by the ability 
of this chimera to occlude Ca*’ in the presence of 
CrATP. This is seen in Fig. 3, which shows the measure- 
ment of occluded Ca*’ by HPLC in a TSK G 4000 SW 
size exclusion column (cf. [8] and [21]). The chimeric 
protein eluted together with a peak of radioactive 
45Ca2+, which was absent from the control sample con- 
taining microsomes from COS cells mock-transfected 
with the expression vector without insert. Experiments 
with wild-type Ca*+-ATPase showed a peak of occluded 
Ca*’ of the same magnitude as that observed for Chi- 
mera A (not shown, but see [S]). 
The ability of Chimera A to occlude Ca*’ not only 
demonstrated that the Ca*+ binding sites functioned, 
but to allow CrATP to stabilize Ca*+ occlusion the ATP 
binding site must also have been relatively intact in this 
chimera. It should be noted that in the normal reaction 
cycle the binding of Ca*+ and ATP is followed by trans- 
fer of the terminal phosphoryl group of ATP to the 
enzyme. This reaction is, however, not required for Ca*+ 
occlusion supported by CrATP [8,21]. 
The abilities of the chimeric ATPases to phospho- 
rylate were tested using radioactive [Y-~*P]ATP and 32Pi. 
We found that Chimera A was able to form an acid- 
stable phosphoenzyme with a steady-state concentra- 
tion similar to that of the wild-type Ca*‘-ATPase in the 
presence of 2 PM [Y-~*P]ATP and micromolar concen- 
t 
10 
Retention time (min) 
I 
15 
Fig. 3. Measurement of CrATP-supported Ca*+ occlusion in Chimera 
A. The Ca2’-occluded enzyme was formed by incubation of the micro- 
somal membranes in the presence of 10 ,uM 45CaZ+ and CrATP as 
described in Section 2. Following centrifugation to remove insoluble 
material 250~1 sample was injected into the HPLC column. The eluant 
contained 5 mg &Es/ml, 0.1 M NaCl, 50 mM TES (pH 7.0), 1.5 mM 
“‘CaC&, 1 .O mM EGTA, and 10 mM MgCI,. Fractions of 0.5 ml were 
collected for analysis of radioactivity (ordinate) or immunoreactivity 
by the blotting technique (inserts). Microsomes were harvested from 
COS-1 cells transfected with cDNA encoding Chimera A (0) or from 
cells transfected with the expression vector without insert (0). The 
blots shown as inserts are aligned so that the lanes are right below the 
corresponding points. 
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trations of Ca2+. In contrast, Chimera B was unable to 
form any detectable phosphoenzyme under these condi- 
tions. Neither did increased levels of Ca2’ (up to 10 
mM) and of ATP (10 AM) induce phosphoenzyme for- 
mation in Chimera B, and substitution of Na’ (100 
mM) for K+ in the reaction buffer was also without 
effect (not shown), although two thirds of Chimera B 
is derived from the Na’,K’-ATPase, and Na+ activates 
phospho~lation from ATP in the wild-type Na+,K+- 
ATPase. In Chimera A, the presence of 100 mM Na+ 
in the absence of Ca2+ and K’ was likewise unable to 
activate phosphorylation from ATP. 
0 
c 
A 
I I I 7 
0 1 
[ATP: (PM) 
3 4 
9 8 7 6 5 4 
pCa 
Fig. 4. ATP and Ca*+ dependencies of phosphoryiation from ATP of 
wild-type Ca*+-ATPase and Chimera A. Phospho~lation of the mi- 
crosomal fractions isolated from COS-1 cells transfected with cDNA 
encoding either wild-type Ca2’-ATPase (III) or Chimera A (0) was 
carried out at 0 “C for 15 s in the presence of 20 mM MOPS buffer 
(pH 7.0), 80 mM K’, 5 mM Me and various concentrations of 
[r-32PJ4TP and Ca*+. (A) Varying [ATP] and constant [CY’] 
(lOO@Q (B) varying [Ca*+] and constant [ATP] (2 PM). The acid- 
quenched 3zP-phospho~la~ samples were subjected to SDS-poly- 
acrylamide gel electrophoresis at pH 6.0, and the autoradiograms of 
the dried gels were quantitated by de&tome&y. The specihc 
phosphorylations are shown as percentages of their maximal values. 
Mean values of duplicate determinations are shown with the error bar 
indicating the largest deviation from the mean. 
wild-type 
Caf’-ATPaSt? 
Chimera A 
Chimera B 
Control 
[Ca2+] 0 0.1 1 10 mM 
Fig. 5. Ca’+ dependency of phospho~lation from P,. Phospho~lation 
of microsomes isolated from COS-1 cells transfected with cDNA en- 
coding either wild-type Ca*‘-ATPase, Chimera A, or Chimera B, or 
of microsomes isolated from cells transfected with vector without 
insert (‘Control’) was carried out at 25 “C for 10 min in the presence 
of 100 mM MES/Tris buffer (pH 6.0), 5 mM Mg?‘, 30% (v/v) dimeth- 
ylsulfoxide, 500 PM [“PIP,, and 2 mM EGTA (‘0’) or the indicated 
Ca” con~ntrations. The acid-quench~ ‘*P-phospho~lat~ samples 
were subjected to SDS-poly~~l~ide gel electrophoresis at pH 6.0, 
and the autoradiograms of the dried gels are shown. 
The ATP-concentration dependencies of phosphoryl- 
ation of wild-type Ca”-ATPase and Chimera A were 
compared by varying the ATP-concentration between 
0.05 PM and 4 ,uM at a constant (saturating) Ca” con- 
centration of 100 ,uM. As seen in Fig. 4A, the apparent 
aflinity for ATP displayed by Chimera A was identical 
to or perhaps even slightly higher than that of the wild- 
type Ca2+-ATPase. The effect of Ca2’ con~ntration on 
formation of phosphoenzyme from ATP was analysed 
in a similar way, and no difference was detected between 
the wild type and Chimera A (Fig. 4B). Since the bind- 
ing of two calcium ions is required for activation of the 
transfer of the y-phosphor@ group of ATP to the en- 
zyme [22], it may be deduced that either Ca2’ site was 
intact in Chimera A, as also indicated by the occlusion 
experiment. Thus, it seems that Chimera A retained the 
full capability to react with ATP and Ca2’, but some- 
how was unable to proceed the reaction cycle and trans- 
port Ca2+. 
Both the Ca*‘-ATPase and the Na’,K’-ATPase can 
be phosphorylated ‘back door’ by inorganic phosphate 
(P,), when the enzymes are in the E2 conformation. Fig. 
5, first lane ([Ca”] = ‘O’), shows the result of an exper- 
iment in which the abilities of the chime& ATPases to 
phosphorylate from Pi were examined under optimum 
conditions for stabilization of the E21E2P forms, in the 
absence of Ca’+, Na+, and K’, and in the presence of 
the organic solvent dimethylsulfoxide, which is known 
to promote the binding of Pi, possibly due to an effect 
on the structure of water [23]. The level of phospho~l- 
ation from Pi was very low in Chimera A and could 
hardly be distinguished from the background. By con- 
trast, Chimera B phosphorylated from Pi. Although, as 
seen in Fig. 5, the amount of phosphoprotein was lower 
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wild-type Ca’+-ATPase Chimera A 
ADP EGTA ADP EGTA 
4 J c 4 
A 
10s 30s 10s 30s 
ADP 
4 
ADP 
4 
B 
Fig. 6. Examination of the phosphoenxyme intermediates formed from 
ATP in the wild-type Ca”-ATPase and Chimera A. (A) Phosphoryla- 
tion was carried out in the presence of 2 PM [Y-‘~P]ATP for 15 s at 
0 “C in 20 mM MOPS buffer (pH 7.0), 80 mM K+, 5 mM Mg*+, 0.1 
mM Ca2’ and 2 pM of the calcium ionophore A23187 (to ensure that 
the Ca*’ concentration was the same on both sides of the membrane). 
The phosphorylated sample was acid quenched irectly (first lane), or 
the ADP-sensitivity was tested by addition of 1 mM ADP with 1 mM 
EGTA, followed by acid quenching 5 s later (second lane). To examine 
the rate of dephosphorylation i  the forward direction, 1 mM EGTA 
was added followed by acid quenching 10 s (third lane) or 30 s (fourth 
lane) later. (B) Phosphorylation was carried out in the presence of 2 
PM [r-“P]ATP, 100 mM TES/Tris (pH 8.35), 10 mM Mg2+, 50 PM 
Ca*+ and 2 ,uM calcium ionophore A23187 at O’C for 15 s. In the first 
lane, the phosphorylated sample was acid quenched directly. In the 
second lane, the ADP-sensitivity was tested by addition of 1 mM ADP 
with 1 mM EGTA followed by acid quenching 5 s later. 
for Chimera B than for the wild-type Ca”-ATPase, this 
could be accounted for by the lower expression level of 
Chimera B (cf. Fig. 2). Thus, quantitation of the 
amount of phosphoprotein on the gel indicated that on 
a molar basis the phosphorylation of Chimera B was as 
high as that of the wild-type Ca’+-ATPase. Fig. 5 fur- 
ther illustrates that the phosphorylation from P, was less 
sensitive to Ca2+ in Chimera B relative to the wild type. 
In the wild-type Ca”-ATPase, the back-door phospho- 
rylation from P, is inhibited by the binding of Ca2+ with 
high affinity, due to displacement of the conformational 
equilibrium in favor of the El form reacting exclusively 
with ATP and not with P,. In Chimera B, Ca2+ inhibited 
the phosphorylation from P, as well, but the Ca2+ con- 
centration required for this inhibition was higher (0. l-l 
mM) than for the wild type (about 10 PM). These data 
show that the Ca2’ site responsible for inhibition of 
phosphorylation from Pi was functioning in Chimera B, 
albeit with reduced affinity. 
The finding that Chimera A formed a phosphorylated 
intermediate from ATP, but not from P,, combined with 
the inability of the chimera to transport Ca”, led us to 
examine the partial reactions following phosphoryla- 
tion from ATP, i.e. the conversion of the ADP-sensitive 
phosphoenzyme intermediate (ElP) to the ADP-insen- 
sitive phosphoenzyme intermediate (E2P) and the sub- 
sequent hydrolysis of E2P with liberation of P,. In the 
252 
experiments described in Fig. 6A, the phosphorylation 
with ATP was performed at pH 7.0 in the presence of 
K’. Under these conditions the major steady-state inter- 
mediate was the ADP-sensitive ElP form, both in the 
wild-type Ca*‘-ATPase and in Chimera A, as demon- 
strated by the complete disappearance of the 
phosphoenzyme upon a Ss-incubation with ADP. In the 
presence of ADP, dephosphorylation can occur through 
reversal of the phosphorylation with resulting synthesis 
of ATP from ADP and the phosphorylated ElP en- 
zyme. When, on the other hand, EGTA was added with- 
out ADP, all the phosphoenzyme present at steady state 
disappeared rapidly in the wild-type Ca2’-ATPase, but 
in contrast the dephosphorylation was extremely slow 
in Chimera A. The addition of EGTA terminates the 
phosphorylation by chelation of Ca”, permitting obser- 
vation of the dephosphorylation of ElP that occurs 
through conversion of ElP to E2P and hydrolysis of the 
latter intermediate. The data in Fig. 6A therefore sug- 
gested that the ElP+E2P interconversion was blocked 
in the chimera. This hypothesis was further substanti- 
ated by phosphorylation experiments conducted at pH 
8.35 in the absence of K’, as shown in Fig. 6B. In the 
wild-type Ca2’-ATPase, these conditions favor accumu- 
lation of ADP-insensitive E2P in steady state, due to a 
reduced rate of E2P hydrolysis. Therefore, most of the 
wild-type Ca”-ATPase phosphoenzyme (E2P) is seen to 
remain after the Ss-incubation with ADP. In contrast to 
the wild type, Chimera A did not accumulate E2P after 
15s reaction with ATP in this medium, as demonstrated 
Wild-type 
Ca”-ATPase Chimera A 
A 
0 160 nM 0 160nM 
mapsigargin] 
Wild-type Ca2’-ATPase Chimera B 
0 161601600nM 0 1616016OOnM 
‘Fapsigargin] 
Fig. 7. Effect of thapsigargin on phosphorylation of Chimera A from 
ATP and of Chimera B from P,. (A) Microsomal fractions isolated 
from COS-1 cells transfected with cDNA encoding either wild-type 
Ca2’-ATPase or Chimera A were incubated for 30 min with or without 
160 nM thapsigargin followed by assay of phosphorylation from ATP 
in the presence of 2 PM [y-“P]ATP and 100 PM Ca” as described for 
Fig. 4. (B) Microsomal fractions isolated from COS-1 cells transfected 
with cDNA encoding either wild-type Ca*+-ATPase or Chimera B 
were incubated for 30 min at 25°C with various concentrations of 
thapsigargin as indicated, followed by assay of phosphorylation from 
P, in the presence of 2 mM EGTA as described for Fig. 5. 
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by the complete dephosphorylation obtained upon ad- 
dition of ADP This supports the notion that the con- 
version of ElP to E2P was blocked in Chimera A. 
Thapsigargin, a plant-derived sesquiterpene lactone, 
has been shown to inhibit SR Ca”-ATPase activity, but 
has no effect on the Na+,K’-ATPase or on the plasma 
membrane Ca2’-ATPase [6]. To identify domains in SR 
Ca2+-ATPase important for the interaction with thapsi- 
gargin, we tested the ability of thapsigargin to prevent 
phosphoenzyme formation in Chimera A and Chimera 
B. It is seen in Fig. 7A that incubation with a slight 
molar excess of thapsigargin (160 nM, compare with a 
concentration of around 50 nM of phosphorylation 
sites) led to complete inhibition of phosphoenzyme for- 
mation from ATP in Chimera A as well as in the wild- 
type Ca2+-ATPase xpressed in COS cells. 
In the wild-type Ca2+-ATPase, a molar excess of tha- 
psigargin reduced the phosphorylation level obtained 
with Pi, as well, to less than 10% (Fig. 7B) consistent 
with previous observations on purified enzyme from 
rabbit muscle [5,24]. On the other hand, as seen in Fig. 
7B, there was no effect of thapsigargin on P, phospho- 
rylation in Chimera B. Not even the presence of 1,600 
nM thapsigargin, i.e. more than 20-fold molar excess, 
inhibited the phosphorylation of Chimera B. 
4. DISCUSSION 
The design of the two chimeric proteins constructed 
and characterized in the present study was based on a 
model for P-type ATPases that places ATP-interaction 
with the cytoplasmic part and ion-binding with the 
transmembrane part [24]. This hypothesis was con- 
firmed by the present data. By constructing chimeric 
proteins we have demonstrated that parts from two 
P-type ATPases with different cation selectivity, the SR 
Ca2+-ATPase and Na’,K+-ATPase, are indeed able to 
supplement each other to some extent, and the cation 
selectivity seems not to be associated with the central 
cytoplasmic domain. First of all, it was possible to ex- 
press the chimeric ATPases in COS-1 cells with proper 
membrane insertion, since they could be isolated in the 
endoplasmic reticulum membrane fraction. Neither of 
the two chimeric ATPases was able to transport Ca2+, 
but several partial reactions in the enzymatic cycle were 
found to be intact. CrATP-supported Ca2+ occlusion 
took place in Chimera A, and Ca2’ was able to activate 
phosphorylation from ATP with apparent affinities for 
Ca2+ and ATP very similar to the affinities of wild-type 
Ca2’-ATPase. The central cytoplasmic domain ex- 
changed in Chimera A contains a number of short seg- 
ments which are highly conserved within the P-type 
family, and which based on affinity labeling are believed 
to interact with ATP. There are, however, also a large 
number of non-conserved residues, and several gaps in 
the alignment (Fig. 8), the overall sequence homology 
between the Ca2+- and Na+,K’-ATPase being no more 
349-CSDKTGTLTTNQMSVCKMFIIDKVDZDFCSLNEFSI'I'.XTyAPEGEVLKNDKPIRS 
::::::::: : :.: : 
369-CSDKTGTLTQNRMTVAHMWFDN QIHEADlTENiSGVSFD 
GQFDGLVELATICALCNDSSLDFNE TKGVYEKVGEATETALTTLVEKMNVFNTRVRN 
:.:.:.:: .: 
KTSATWFAiSR;A&tAVpQ&QENLPILKFAVAGDAsESALLKCIEVCCGSVMtiE 
LSKVERANACNSVIRQLNKKEFTLEFSRDRKSMSVYCSPAKSSRAAVG NFMFVKGAPRGV 
. : ::::I 
KYTKIV EIPFNS&YQLSIHKNpNA;EPK HLLVMKGAPER; 
IDRCNYVRV GTTRVPNTGPVKEKILSVIKENG'XRDTLRCLALATRDTPPKREEMVLDD 
.::: ..: .:. 
LDRCSSILLHGKRQ ~LDEELKDAFQNAYLEL~G LGE&&FCHLLL~DEQFPEGFQF 
SSRFMEYET DLTFVGWGMLDPPRKE"MGSIQLCRDAGIRVIMITGDNKGTAIAICRRI 
. . : :::.. :.:::: : . :: :::.:::.::: :: :: . . 
DTDEVNFPVDNLCFVGLISMIDPPRAAVPDAVGKCRSAGIKVIMVTGDHPITAKAIAKGV 
GIFGENEEVAD RAYTGREFDDLPLAEQREACRRA CCFA 
:: : : 
GIIsEGN&DIAARLNIPVNQVNPRDAKACWH&DLK&SE~LD~IL~yHT&~ 
RVEPSHKSKIVEYLQSYDEITAMTGDGV-705 
::: ::::: 
;TS;QQ;LIIVEGC;RQGA%TGCGV-714 
Fig. 8. Alignment of the amino acid sequences of the SR Ca*+-ATPase 
(upper) and the Na+,K+-ATPase (lower) corresponding to the central 
cytoplasmic domain, which was exchanged in Chimera A. One and 
two dots indicate conservative replacements and identical residues, 
respectively. 
than 35% in this domain. From the present data it can 
be concluded that these non-conserved residues in the 
central cytoplasmic domain are without major impor- 
tance for determination of cation selectivity and affin- 
ity. Moreover, the non-conserved residues can be ex- 
changed without any apparent change in the interaction 
of the enzyme with ATP. 
By contrast, Ca2’ did not activate phosphoenzyme 
formation from ATP in Chimera B, although Ca2+ in- 
hibited the phosphorylation from P,. This finding is 
most easily interpreted in terms of a stepwise mecha- 
nism for binding of two calcium ions, in which the 
binding of the tist calcium ion is sufficient to prevent 
phosphorylation from P,, whereas the binding of both 
calcium ions is required for activation of phosphoryla- 
tion from ATP [ 13,22,25]. Based on this model, it seems 
that the site binding the first calcium ion in the sequence 
was functioning in Chimera B, whereas the site binding 
the second calcium ion may have been disrupted. Thus, 
the data point to a location of the second site in the 
NH,-terminal one third of the molecule, which differs 
between Chimera A and Chimera B. Moreover, since 
the apparent affinity with which Ca2’ inhibited phos- 
phorylation from P, was somewhat reduced in Chimera 
B, it is possible that in addition the NH,-terminal one 
third of the molecule contributes residues to the first 
site. The combined evidence from the present data and 
studies of point mutants [3,7,8,11,13,14] would suggest 
that the major part of the residues forming the first site 
are contributed from the putative transmembrane seg- 
ments M5, M6, and M8, and that M4 (perhaps also M3) 
constitutes a central element in formation of the second 
site with some contribution to the first site. A close 
proximity of the two Ca2+ sites is also supported by 
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kinetic evidence of dissociation of both ions through a 
common access channel [21,22]. 
The inability of Chimera A to transport Ca*+ could 
be traced to a block of the ElP+E2P conformational 
change, the crucial energy transducing event in the 
transport cycle, which leads to deocclusion of Ca*’ at 
the luminal surface and to loss of ADP sensitivity of the 
phosphoenzyme [26,27]. In Chimera A, formation of 
E2P was also blocked in the reverse direction from E2, 
as indicated by the lack of phosphorylation from P,. 
Since the latter function was intact in Chimera B, it 
seems reasonable to ascribe the lack of E2P formation 
in Chimera A to a defective interaction of the NH*- 
terminal one third of the molecule contributed from 
Ca2+-ATPase with the central cytoplasmic domain con- 
tributed from Na+,K+-ATPase. This information sup- 
plements previous demonstrations of the involvement 
of single highly conserved residues in ElP+E2P transi- 
tion [12]. 
Finally, the present study provided information on 
the location of residues of importance for the specific 
interaction of the SR Ca*‘-ATPase with thapsigargin. 
Thapsigargin has been shown to inhibit high-affinity 
Ca*+ binding, but it is not well understood whether this 
inhibition is due to a direct interaction with one or both 
Ca*’ binding sites, or thapsigargin acts indirectly by 
stabilizing a conformation (E2) with low affinity [5,24]. 
Since Chimera A was inhibited by thapsigargin, 
whereas Chimera B was not, it appears that residues 
conferring thapsigargin sensitivity are located in the 
NH,-terminal one third of the molecule. Recently, it 
was reported that the first 200 amino acid residues of 
the Ca*‘-ATPase are without importance for thapsi- 
gargin sensitivity [28]. In combination with our result 
this data places the residues crucial to thapsigargin 
binding within the segment between residue 200 and 
residue 348. On the basis of the hydrophobic nature of 
thapsigargin one would suggest that transmembrane 
segments M3 and/or M4 might be involved. 
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